Market Place
Market Place
Post Enquiry
FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments
This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s
US DMF filings indicate a robust API industry, with multiple first-to-file challenges
This week, PharmaCompass brings you a compilation of the Drug Master Files (DMFs) updates at
